Verotoxin/globotriaosyl ceramide recognition: Angiopathy, angiogenesis and antineoplasia

Bioscience Reports

Volumn 19, Issue 5, 1999, Pages 345-354

  Lingwood, C A ^a  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

Apoptosis; Astrocytoma; Bone marrow purging; Glycolipid; Intracellular traffic; Multidrug resistance; Ovarian carcinoma; Post transplant lymphoproliferative disease

Indexed keywords

GLOBOTRIAOSYLCERAMIDE; GLYCOLIPID; LIPID; MULTIDRUG RESISTANCE PROTEIN; VEROTOXIN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CELL NUCLEUS MEMBRANE; ENDOPLASMIC RETICULUM; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC COLITIS; IN VITRO STUDY; INTRACELLULAR TRANSPORT; MICROANGIOPATHY; MOLECULAR RECOGNITION; NONHUMAN; SHORT SURVEY; VASCULAR DISEASE;

GLOMERULUS;

EID: 0033510306     PISSN: 01448463     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020299819637     Document Type: Short Survey

References (61)

1. Arab, S. et al. (1998) Verotoxins inhibit the growth of and induce apotosis in human astrocytoma cells. J. Neuro. Oncol. 40:137-150.
2. Arab, S., and Lingwood, C. (1998) Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to Verotoxin : sodium butyrate or selection of drug resistance may induce nuclear toxin targeting via globotriosyl ceramide fatty acid isoform traffic. J. Cell Physiol. 177:646-660.
3. Arab, S., Russel, E., Chapman, W., Rosen, B., and Lingwood, C. (1997) Expression of the Verotoxin receptor glycolipid, globotriaosylceramide, in Ovarian Hyperplasias. Oncol. Res. 9:553-563.
4. Arab, S., Rutka, J., and Lingwood, C. (in press) Verotoxin induces apoptosis and the complete, rapid, long term elimination of human astrocytoma xenografts in nude mice. Oncol. Res.
5. Bitzan, M., Richardson, S., Huang, C., Boyd, B., and Karmali, M. A. (1994). In: 2nd International Symposium and Workshop on Verocytotoxin (Shiga-like)-producing Escherichia coli infections, (ed.) Bergamo, Italy: pp. 25.
6. Bitzan, M. M., Wang, Y., Lin, J., and Marsden, P. A. (1988) Verotoxin and ricin have novel effects on preproendothelin-1 expression but fail to modify nitric oxide synthase (ecNOS) expression and NO production in vascular endothelium. J. Clin. Invest. 101:473-382.
7. Boulanger, J. et al. (1990) Neutralization receptor-based immunoassay (NeutrELISA) for detection of neutralizing antibodies to Escherichia coli verocytotoxin 1. J. Clin. Micro. 28:2830-2833.
8. Cohen, A. et al. (1990) Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease. Int. Immunol. 2:1-8.
9. k antigen) and a novel platelet glycosphingolipid. Infect. Immun. 66:4355-4366.
10. Farkas-Himsley, H., Rosen, B., Hill, R., Arab, S., and Lingwood, C. A. (1995) Bacterial colicin active against tumour cells in vitro and in vivo is verotoxin 1. Proc. Natl. Acad. Sci. 92:6996-7000.
11. Ghislain, J., Lingwood, C. A., and Fish, E. N. (1994) Evidence for glycosphingolipid modification of the type 1 IFN receptor. J. Immunol. 153:3655-3663.
12. Hughes, A. K., Stricklett, P. K., and Kohan, D. E. (1988) Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells. Kid. Intl. 54:426-437.
13. Inward, C. D. et al. (1995) Verocytotoxin-1 induces apoptosis in vero cells. J. Infect. Dis. 30:213-218.
14. Jacewicz, M., Feldman, H. A., Donohue-Rolfe, A., Balasubramanian, K. A., and Keusch, G. T. (1989) Pathogenesis of Shigella diarrhoea. XIV. Analysis of Shiga toxin receptors on cloned HeLa cells. J. Infect. Dis. 159:881-889.
15. Kaplan, B. S., Cleary, T. G., and Obrig, T. G. (1990) Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes. Pediatr. Nephrol. 4:276-283.
16. Kaplan, B. S., Thomson, P. D., and de Chadarevian, J. P. (1976) The hemolytic-uremic syndrome. Pediatr. Clin. North. Am. 23:761-777.
17. Keusch, G. T., Acheson, D. W. K., Aaldering, L., Erban, J., and Jacewicz, M. S. (1996) Comparison of the effects of Shiga-like toxin 1 on cytokine-and butyrate-pretreated human umbilical and saphenous vein endothelial cells. J. Infect. Dis. 173:1164-1170.
18. Khine, A. A., Firtel, M., and Lingwood, C. A. (1998) CD77-dependent retrograde transport of CD19 to the nuclear membrane: Functional relationship between CD77 and CD19 during germinal center B-cell apoptosis. J. Cell Physiol. 176:281-292.
19. 2 interferon/type I interferon receptor mediated anti viral activity. J. Cell Physiol.
20. Kiarash, A., Boyd, B., and Lingwood, C. A. (1994) Glycosphingolipid receptor function is modified by fatty acid content: Verotoxin 1 and Verotoxin 2c preferentially recognize different globotriaosylceramide fatty acid homologues. J. Biol. Chem. 269:11138-11146.
21. LaCasse, E. C., Saleh, M. T., Patterson, B., Minden, M. D., and Gariépy, J. (1996) Shiga-like toxin purges human lymphoma from bone marrow of severe combined immunodeficient mice. Blood 88:1561-1567.
22. Lieberman, E., Heuser, E., Donnel, G., Landing, B., and Hammond, G. (1966) Hemolytic Uremic Syndrome. Clinical and pathological considerations. New Engl. J. Med. 275:227-236.
23. Lingwood, C. A. (1993) In: Advances in Lipid Research (R. Bell, Y. A. Hannun and A. Merrill Jr. (eds.) San Diego: Academic Press, pp. 189-212.
24. Lingwood, C. A. (1994) Verotoxin-binding in human renal sections. Nephron 66:21-28.
25. Lingwood, C. A. (1996) Role of verotoxin receptors in pathogenesis. Trends in Microbiol. 4:147-153.
26. Lingwood, C. A., and Yiu, S. C. K. (1992) Glycolipid modification of α-interferon binding: Sequence similarity between α-interferon receptor and the verotoxin (Shiga-like toxin) B-subunit. Biochem. J. 283:25-26.
27. Li, S.-C., Kundu, S. K., Degasperi, R., and Li, Y.-T. (1986) Accumulation of globotriaosylceramide in a case of leiomyosarcoma. Biochem. J. 240:925-927.
28. Louise, C. B., and Obrig, T. G. (1991) Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1β, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect. Immun. 59:4173-4179.
29. Louise, C. B., and Obrig, T. G. (1992) Shiga toxin-associated hemolytic uremic Syndrome: combined cytotoxic effects of Shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect. Immun. 60:1536-1543.
30. Maloney, M. D., and Lingwood, C. A. (1994) CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: Implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis. J. Exp. Med. 180:191-201.
31. Mangeney, M. et al. (1993) Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen. Cancer Res. 53:5314-5319.
32. Mangeney, M., Richard, Y., Coulaud, D., Tursz, T., and Wiels, J. (1991) CD77: an antigen of germinal center B cells entering apoptosis. Eur. J. Immunol. 21:1131-1140.
33. Milford, D. V. et al. (1990) Haemolytic uraemic syndrome in the British Isles, 1985-1988: association with Verocytoloxin producing Escherichia coli. Part I: Clinical and epidemiological aspects. Arch. Dis. Child. 65:716-721.
34. Montone, K. T. et al. (1996) Analysis of Epstein Barr virus-associated posttransplantation lympho-proliferative disorder after lung transplantation. Surgery 119:544-551.
35. Morrison, V. A., Dunn, D. L., Manivel, J. C., Gajl-Peczalska, K. J., and Peterson, B. A. (1994) Clinical characteristics of post-transplant lymphoproliferative disorders. Am. J. Med. 97:14-24.
36. Mylvaganam, M., and Lingwood, C. (1999) Adamantyl globotriaosyl ceramide a water soluble glycolipid mimic which inhibits verotoxin receptor binding. Biochem. Biophys. Res. Commun. 257:391-394.
37. Newburg, D. et al. (1993) Susceptibility to hemolytic-uremic syndrome relates to erythrocyte glycosphin-golipid patterns. J. Infect. Dis. 168:476-479.
38. Nudelman, E. et al. (1983) A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody. Science 220:509.
39. Nyholm,P. G. et al. (1966) Two distinct binding sites for globotriaosyl ceramide on verotoxins: molecular modelling and confirmation by analogue studies and a new glycolipid receptor for all verotoxins. Chem. Biol. 3:263-275.
40. Obrig, T. G. et al. (1988) Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect. Immun. 56:2373-2378.
41. Obrig, T. et al. (1993) Endothelial heterogeneity in Shiga toxin receptors and responses. J. Biol. Chem. 268:15484-15488.
42. Obrig, T. G. (1998) In Escherichia coli O157: H7 and Other Shiga Toxin-Producing E. coli Strains (Kaper, J. B., and O'Brien, A. D., eds), Washington, D.C.: American Society for Microbiology, pp. 303-311.
43. Pellizzari, A., Pang, H., and Lingwood, C. A. (1992) Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content. Biochem. 31:1363-1370.
44. Pudymaitis, A., and Lingwood, C. A. (1992) Susceptibility to verotoxin as a function of the cell cycle. J. Cell Physiol. 150:632-639.
45. Ramegowda, B., and Tesh, V. L. (1996) Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines. Infect. Immun. 64:1173-1180.
46. Riley, L. W. et al. (1983) Hemorrhagic colitis associated with a rare Escherichia coli serotype. New Eng. J. Med. 308:681-685.
47. Robinson, L. A., Hurley, R. M., Lingwood, C. A., and Matsell, D. G. (1995) "Escherichia coli verotoxin binding to human paediatric glomerular mesangial cells". Ped. Nephrol. 9:700-704.
48. Rowe, P., Orrbine, E., Wells, G., and McLaine, P. (1991) Epidemiology of the hemolytic-uremic syndrome in Canadian children from 1986-1988. J. Pediat. 119:218-224.
49. Sakiri, R., Ramegowa, B., and Tesh, V. L. (1998) Shiga toxin type 1 activates tumor necrosis factor-α gene transcription and nuclear translocation of the transcriptional activators nuclear factor-kB and activator protein-1. Blood 92:558-566.
50. Siegler, R., Pysher, T., Tesh, V., and Taylor, E. (1988) Primate response to single and divided doses of Shiga-like toxin 1. Ped. Nephrol. 12:C74.
51. Simon, M., Cleary, T., Hernandez, J., and Abboud, H. (1998) Shiga toxin 1 elicits diverse biological responses in mesangial cells. Kid. Intl. 54:1117-1127.
52. St. Hilaire, P. M., Boyd, M. K., and Toone, E. J. (1994) Interaction of the Shiga-like toxin type 1 B-subunit with its carbohydrate receptor. Biochem. 33:14452-14463.
53. Taga, S., Manganey, M., Tursz, T., and Wiels, J. (1995) Differential regulation of glycosphingolipid biosynthesis in phenotypically distinct Burkitt's lymphoma cell lines. Int. J. Cancer 61:261-267.
54. van der Kar, N. C. A. J., Monnens, L. A. H., Karmali, M., and van Hinsbergh, V. W. M. (1992) Tumor necrosis factor and interleukin-1 induce expression of the verotoxin receptor globotriaosyl ceramide on human endothelial cells: Implications for the pathogenesis of the Hemolytic Uremic Syndrome. Blood 80:2755-2764.
55. van der Kar, N. C. J. et al. (1995) Tumor necrosis factor a induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinaseC. Blood 85:734-743.
56. van Setten, P. et al. (1997) Effects of TNFα on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Intl. 51:1245-1256.
57. van Setten, P., Monnens, L., Verstraten, R., van der Heuvel, L., and van Hinsberg, V. (1996) Effects of verotoxin-1 on non-adherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood 88:174-183.
58. Wenk, J. et al. (1994) glycolipids of germ cell tumors: extended globo-series glycolipids are a hallmark of human embryonal carcinoma cells. Int. J. Cancer 58:108-115.
59. Williams, J. et al. (1998) A comparison of the effects of verocytotoxin-1 on primary human renal cell cultures. Toxicol. Lett. 105:47-57.
60. Yamasaki, C. et al. (1999) Induction of cytokines in a human colon epithelial cell line by Shiga toxin 1 (Stx1) and Stx2 but not by non-toxic mutant Stx1 which lacks N-glycosidase activity. FEBS Lett. 442:231-234.
61. Yoshimura, K. et al. (1998) No direct effects of shiga toxin 1 and 2 on the aggregation of human platelets in vitro. Thromb Haemost 80:529-530.